Krystexxa medication / VISN 2 / syracuse VAMC / FY20 / Q1
Ended Awarded
- Contract number
- 36C24220N0305
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $45,203
Award facts
- Contract value 100% obligated
- $45,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Forest, IL 60045, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed price blanket purchase agreement (BPA) call was awarded on December 12, 2019 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 to Horizon Therapeutics USA Inc. The $45,203.20 contract is for the delivery of KRYSTEXXA medication to the Syracuse VA Medical Center in New York to support patient care programs during the first quarter of fiscal year 2020. Issued against the company's Pharmaceuticals and Drugs schedule (FSS-61-IB) under the General Services Administration Multiple Award Schedule program, the single award contract has a period of performance through December 16, 2019 to fulfill the stated requirements. No set-aside designation was applied to this procurement.
Quick answers
Who was awarded contract 36C24220N0305?
36C24220N0305 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on December 12, 2019.
How much is contract 36C24220N0305 worth?
The government has obligated $45,203 on 36C24220N0305.
Is contract 36C24220N0305 an order under another contract?
Yes. 36C24220N0305 is a BPA call under 36F79719D0224-36E79719A0032, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24220N0305 competed?
The extent of competition for 36C24220N0305 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award